Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-25

Clinical Trial Update: Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch

View source ↗

Summary

A completed clinical trial comparing sleep and quality of life in patients with glycogen storage disease on standard versus modified uncooked cornstarch.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Uncooked cornstarch (modified dosing) (uncooked cornstarch)
  • Uncooked cornstarch (standard dosing) (uncooked cornstarch)

Snippet

Sponsor: John Mitchell | Conditions: Glycogen Storage Disease Type IA, Glycogen Storage Disease Type IB | Status: COMPLETED